1383682-75-4Relevant academic research and scientific papers
OXINDOLOPYRIMIDINE AS IGF1R RECEPTOR INHIBITORS
-
Page/Page column 72, (2012/07/13)
The present invention encompasses compounds of general formula (I) wherein the groups R5 to R10, A, L1, B, m and p are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
